Page last updated: 2024-09-04

irofulven and Leukemia, Myeloid, Acute

irofulven has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Kornblau, S; Kwari, M; Murgo, A1

Trials

1 trial(s) available for irofulven and Leukemia, Myeloid, Acute

ArticleYear
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia.
    Investigational new drugs, 2001, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Camptothecin; Drug Administration Schedule; Hematologic Tests; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Survival Rate

2001